Truist Financial Sticks to Their Buy Rating for Nucana (NCNA)

TipRanksOct 16 03:00 ET · Ratings

Truist Slashes Price Target on NuCana to $20 From $150 Amid Discontinuation of NUC-3373, Keeps Buy Rating

MT NewswiresOct 15 07:54 ET · Ratings

A BioRxiv Medical Journal Article Has Been Published Today On Nucana "A Phosphoramidate Modification Of FUDR, NUC-3373, Causes DNA Damage And DAMPs Release From Colorectal Cancer Cells, Potentiating Lymphocyte-Induced Cell Death"

BenzingaOct 11 12:23 ET

NuCana Plc Enhances Offering to $5.4 Million

TipRanksOct 1 06:29 ET

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

MT NewswiresSep 26 11:07 ET

Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket

BenzingaSep 26 06:31 ET